Wavegate
Private Company
Funding information not available
Overview
Wavegate is a neuromodulation company pioneering a next-generation, closed-loop spinal cord stimulation system for chronic pain. Its Ellipse platform uniquely uses optical reflectometry (StimuLux) to monitor spinal cord position in real-time and automatically adjust electrical stimulation, addressing a key limitation of traditional open-loop SCS systems. The technology is designed to improve clinical outcomes by maintaining a consistent dose regardless of patient movement, positioning the company in the high-growth chronic pain neuromodulation market. Led by a seasoned team of medtech executives and clinicians, Wavegate is advancing its platform toward commercialization.
Technology Platform
Ellipse spinal cord stimulator platform integrated with StimuLux optical reflectometry for real-time, closed-loop, motion-responsive dosing.
Opportunities
Risk Factors
Competitive Landscape
Wavegate competes in the spinal cord stimulation market against large, established medtech companies like Abbott, Boston Scientific, Medtronic, and Nevro, several of whom already market closed-loop SCS systems. Its success hinges on proving that its optical reflectometry-based Active Loop technology provides a tangible clinical or usability advantage over existing closed-loop methods.